AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliphonite M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Inrus Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gliphonite M 1mg/500mg Tablet

Diabetic patients using the dual-action medication, Glyconia-M (1mg/500mg), should be aware that it's a combined anti-diabetic formulation for adult type 2 diabetes management. This medication assists in regulating blood glucose, and should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, Glyconia-M is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular mealtimes and carry a readily available fast-acting sugar source (e.g., glucose tablets, juice). Alcohol consumption should be minimized due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Glyconia-M is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should consult their physician prior to commencing treatment. Pregnant or lactating women should seek medical advice before using this medication. Routine blood glucose monitoring is essential, along with potential blood tests to monitor blood cell counts and liver function.

Uses of Gliphonite M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Gliphonite M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Gliphonite M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.

Common Side effects of Gliphonite M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliphonite M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliphonite M 1mg/500mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Gliphonite M 1mg/500mg Tablet works:

Gliphonite M, a 1mg/500mg tablet, unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliphonite M 1mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliphonite M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Consult your physician for advice.

Breast feedingBreast feedingUNSAFE

Lactation and Gliphonite M 1mg/500mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliphonite M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Gliphonite M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliphonite M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a low dose; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Gliphonite M 1mg/500mg Tablet :

Should you forget a Gliphonite M 1mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliphonite M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliphonite M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Gliphonite M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is particularly risky for individuals with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Gliphonite M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliphonite M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliphonite M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake at least annually is recommended by some researchers.
Gliphonite M 1mg/500mg tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gliphonite M 1mg/500mg tablets and alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Gliphonite M 1mg/500mg Ta...
73
MRP 85
14% off